Quantcast
Last updated on April 19, 2014 at 13:20 EDT

Latest Vermillion Stories

2013-08-13 12:31:23

Brings 200 Jobs to Vermillion Community VERMILLION, S.D., Aug. 13, 2013 /PRNewswire/ -- Eagle Creek Software Services, the leader in onshore information technology services, and the Vermillion Area Chamber and Development Company (VCDC) broke ground today on the Vermillion Technology Center. When fully staffed, the center expects to house 200 highly skilled IT workers. (Logo: http://photos.prnewswire.com/prnh/20130313/CL76399LOGO) The Vermillion Technology Center is a major piece...

2013-03-13 16:28:49

New $10-Million Technology Center to Open in Vermillion, S.D.; Scholarships and Career Track at University of South Dakota Will Train Workforce VERMILLION, S.D., March 13, 2013 /PRNewswire/ -- Eagle Creek Software Services, the leader in onshore information technology services, announced today a partnership with the state of South Dakota and city of Vermillion to bring 1,000 jobs to the state. The rural high-tech jobs will be phased in over the next 3-5 years. A new $10 million...

2012-06-15 06:23:59

AUSTIN, Texas, June 15, 2012 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a leading molecular diagnostics company, reported that results of the recent Peripheral Artery Disease (PAD) multi-marker intended use study were presented this week at the Society for Vascular Medicine's 23rd Annual Scientific Sessions, in Minneapolis, MN. This meeting hosts the nation's leading vascular medicine specialists, and includes sessions on PAD guidelines, policy trends, and advances in the diagnosis and...

2012-03-06 07:30:00

AUSTIN, Texas, March 6, 2012 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a leading molecular diagnostics company, reported that the American Medical Association (AMA) Current Procedural Terminology (CPT®) Panel has voted to approve an application for a Category 1 CPT code for its OVA1® test, which is designed to help differentiate benign versus malignant ovarian masses. The AMA recently disclosed the new code on its website, which will become effective January 1, 2013. "This...

2011-09-06 07:00:00

AUSTIN, Texas, Sept. 6, 2011 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a molecular diagnostics company, today announced that the United States Patent and Trademark Office (USPTO) has issued patent number 8,014,952 entitled " Serum Biomarkers in Lung Cancer " to the Company. "This patent highlights on-going progress in expanding our intellectual property portfolio. Beyond our core focus areas of ovarian cancer and peripheral artery disease, we now have patents in lung cancer, breast...

2011-08-23 09:58:00

VERMILLION, S.D., Aug. 23, 2011 /PRNewswire-USNewswire/ -- Journalist and media innovator Brian P. Lamb, founder, chairman and chief executive officer of C-SPAN, will be honored as recipient of the Al Neuharth Award for Excellence in the Media, Thursday evening, Oct. 6, at The University of South Dakota. Lamb is the 25th individual selected by the university and the Freedom Forum since the Al Neuharth Award program began in 1989. The award, recognizing lifetime achievement, is named for...

2011-08-01 07:30:00

AUSTIN, Texas, Aug. 1, 2011 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a molecular diagnostics company, today announced that the United States Patent and Trademark Office (USPTO) has issued a notice of allowance for a patent entitled "Biomarkers for Peripheral Artery Disease." The patent claims cover the biomarker alpha1beta glycoprotein and biomarker combinations that include alpha1beta glycoprotein for the diagnosis of PAD. "This will be our third patent for biomarkers that can be...

2011-06-03 19:22:00

AUSTIN, Texas, June 3, 2011 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a molecular diagnostics company, today announced that the company will hold its annual shareholders' meeting as scheduled on Monday June 6th, 2011, at the Hampton Inn, 2013 RR 620 South, Lakeway, Austin TX. The company was notified by the Court of the Chancery of the State of Delaware today that a request to delay the meeting brought by a shareholder, Robert S. Goggin, was denied. About Vermillion: Vermillion,...

2011-05-25 07:30:00

AUSTIN, Texas, May 25, 2011 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a molecular diagnostics company, today announced that the United States Patent and Trademark Office (USPTO) has issued a notice of allowance for a patent entitled "Saposin D and Fam3C are Biomarkers for Alzheimer's Disease." The patent claims cover the biomarkers saposin D and Fam3c as well as combinations that include these biomarkers. "This patent allowance is very significant as it helps create a unique asset...

2011-05-11 08:00:00

AUSTIN, Texas, May 11, 2011 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a molecular diagnostics company, received a First Place Award for its OVA1 Logo from the Diagnostic Marketing Association at their annual summit in San Diego on April 27, 2011. The First Place award was in the category of Product/Service Brand Creation for companies less than $100M. Vermillion also took the 2nd place award in the same category for the OVA1 Scalpel Ad. The award was presented by DxMA Directors...